How much profit has Polynovo made this year?
Polynovo has made 9.46 M AUD this year.
Polynovo Net Income 2025
Polynovo Net Income
9.46 M AUD
Ticker
PNV.AX
ISIN
AU000000PNV0
WKN
A12F4T
In 2025, Polynovo's profit amounted to 9.46 M AUD, a 79.84% increase from the 5.26 M AUD profit recorded in the previous year.
The Polynovo Net Income history
| YEAR | NET INCOME (undefined AUD) |
|---|---|
| 2030e | 48.98 |
| 2029e | 42 |
| 2028e | 35.03 |
| 2027e | 36.72 |
| 2026e | 22.87 |
| 2025e | 9.46 |
| 2024 | 5.26 |
| 2023 | -4.92 |
| 2022 | -1.19 |
| 2021 | -4.61 |
| 2020 | -4.19 |
| 2019 | -3.19 |
| 2018 | -5.97 |
| 2017 | -5.01 |
| 2016 | -3.06 |
| 2015 | -1.3 |
| 2014 | -2.94 |
| 2013 | -1.49 |
| 2012 | -2.7 |
| 2011 | -2.92 |
| 2010 | -1.86 |
| 2009 | -1.83 |
| 2008 | -4.44 |
| 2007 | -13.41 |
| 2006 | -11.29 |
| 2005 | -10.77 |
Polynovo Revenue, EBIT, Net Income AU000000PNV0 · A12F4T
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Polynovo, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Polynovo from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Polynovo’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Polynovo. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Polynovo’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Polynovo’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Polynovo’s growth potential.
Polynovo Revenue, EBIT and net profit per share
| Date | Polynovo Revenue | Polynovo EBIT | Polynovo Net Income |
|---|---|---|---|
| 2030e | 259.13 M undefined | 0 undefined | 48.98 M undefined |
| 2029e | 235.62 M undefined | 58.78 M undefined | 42 M undefined |
| 2028e | 214.14 M undefined | 45.6 M undefined | 35.03 M undefined |
| 2027e | 199.49 M undefined | 44.25 M undefined | 36.72 M undefined |
| 2026e | 161.6 M undefined | 27.02 M undefined | 22.87 M undefined |
| 2025e | 131.1 M undefined | 10.22 M undefined | 9.46 M undefined |
| 2024 | 104.73 M undefined | 2.7 M undefined | 5.26 M undefined |
| 2023 | 66.11 M undefined | -5.32 M undefined | -4.92 M undefined |
| 2022 | 41.44 M undefined | -256,000 undefined | -1.19 M undefined |
| 2021 | 29.16 M undefined | -3.15 M undefined | -4.61 M undefined |
| 2020 | 22.19 M undefined | -4.07 M undefined | -4.19 M undefined |
| 2019 | 13.68 M undefined | -3.54 M undefined | -3.19 M undefined |
| 2018 | 5.99 M undefined | -6.21 M undefined | -5.97 M undefined |
| 2017 | 3.76 M undefined | -5.01 M undefined | -5.01 M undefined |
| 2016 | 3.47 M undefined | -3.33 M undefined | -3.06 M undefined |
| 2015 | 140,700 undefined | -2.93 M undefined | -1.3 M undefined |
| 2014 | 270,000 undefined | -2.94 M undefined | -2.94 M undefined |
| 2013 | 280,000 undefined | -1.57 M undefined | -1.49 M undefined |
| 2012 | 810,000 undefined | -2.83 M undefined | -2.7 M undefined |
| 2011 | 910,000 undefined | -3.35 M undefined | -2.92 M undefined |
| 2010 | 630,000 undefined | -2.72 M undefined | -1.86 M undefined |
| 2009 | 980,000 undefined | -2 M undefined | -1.83 M undefined |
| 2008 | 1.32 M undefined | -3.79 M undefined | -4.44 M undefined |
| 2007 | 1.43 M undefined | -12.59 M undefined | -13.41 M undefined |
| 2006 | 1.29 M undefined | -10.52 M undefined | -11.29 M undefined |
| 2005 | 790,000 undefined | -10.77 M undefined | -10.77 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 790,000 AUD | -10.77 M AUD | -10.77 M AUD |
| 2006 | 1.29 M AUD | -10.52 M AUD | -11.29 M AUD |
| 2007 | 1.43 M AUD | -12.59 M AUD | -13.41 M AUD |
| 2008 | 1.32 M AUD | -3.79 M AUD | -4.44 M AUD |
| 2009 | 980,000 AUD | -2 M AUD | -1.83 M AUD |
| 2010 | 630,000 AUD | -2.72 M AUD | -1.86 M AUD |
| 2011 | 910,000 AUD | -3.35 M AUD | -2.92 M AUD |
| 2012 | 810,000 AUD | -2.83 M AUD | -2.7 M AUD |
| 2013 | 280,000 AUD | -1.57 M AUD | -1.49 M AUD |
| 2014 | 270,000 AUD | -2.94 M AUD | -2.94 M AUD |
| 2015 | 140,700 AUD | -2.93 M AUD | -1.3 M AUD |
| 2016 | 3.47 M AUD | -3.33 M AUD | -3.06 M AUD |
| 2017 | 3.76 M AUD | -5.01 M AUD | -5.01 M AUD |
| 2018 | 5.99 M AUD | -6.21 M AUD | -5.97 M AUD |
| 2019 | 13.68 M AUD | -3.54 M AUD | -3.19 M AUD |
| 2020 | 22.19 M AUD | -4.07 M AUD | -4.19 M AUD |
| 2021 | 29.16 M AUD | -3.15 M AUD | -4.61 M AUD |
| 2022 | 41.44 M AUD | -256,000 AUD | -1.19 M AUD |
| 2023 | 66.11 M AUD | -5.32 M AUD | -4.92 M AUD |
| 2024 | 104.73 M AUD | 2.7 M AUD | 5.26 M AUD |
| 2025e | 131.1 M AUD | 10.22 M AUD | 9.46 M AUD |
| 2026e | 161.6 M AUD | 27.02 M AUD | 22.87 M AUD |
| 2027e | 199.49 M AUD | 44.25 M AUD | 36.72 M AUD |
| 2028e | 214.14 M AUD | 45.6 M AUD | 35.03 M AUD |
| 2029e | 235.62 M AUD | 58.78 M AUD | 42 M AUD |
| 2030e | 259.13 M AUD | 0 AUD | 48.98 M AUD |
Polynovo stock margins AU000000PNV0 · A12F4T
The Polynovo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Polynovo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Polynovo.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Polynovo's sales revenue. A higher gross margin percentage indicates that the Polynovo retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Polynovo's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Polynovo's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Polynovo's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Polynovo. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Polynovo's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Polynovo Margin History
| Polynovo Gross margin | Polynovo Profit margin | Polynovo EBIT margin | Polynovo Profit margin |
|---|---|---|---|
| 2030e | 94.77 % | 0 % | 18.9 % |
| 2029e | 94.77 % | 24.95 % | 17.83 % |
| 2028e | 94.77 % | 21.3 % | 16.36 % |
| 2027e | 94.77 % | 22.18 % | 18.41 % |
| 2026e | 94.77 % | 16.72 % | 14.15 % |
| 2025e | 94.77 % | 7.8 % | 7.22 % |
| 2024 | 94.77 % | 2.58 % | 5.02 % |
| 2023 | 93.29 % | -8.04 % | -7.45 % |
| 2022 | 94.68 % | -0.62 % | -2.88 % |
| 2021 | 94.67 % | -10.79 % | -15.79 % |
| 2020 | 92.32 % | -18.33 % | -18.9 % |
| 2019 | 90.54 % | -25.84 % | -23.31 % |
| 2018 | 89.43 % | -103.64 % | -99.74 % |
| 2017 | 122.51 % | -133.17 % | -133.17 % |
| 2016 | 94.77 % | -95.97 % | -88.22 % |
| 2015 | 94.77 % | -2,080.1 % | -925.73 % |
| 2014 | 94.77 % | -1,088.89 % | -1,088.89 % |
| 2013 | 94.77 % | -560.71 % | -532.14 % |
| 2012 | 94.77 % | -349.38 % | -333.33 % |
| 2011 | 94.77 % | -368.13 % | -320.88 % |
| 2010 | 94.77 % | -431.75 % | -295.24 % |
| 2009 | 94.77 % | -204.08 % | -186.73 % |
| 2008 | 94.77 % | -287.12 % | -336.36 % |
| 2007 | 94.77 % | -880.42 % | -937.76 % |
| 2006 | 94.77 % | -815.5 % | -875.19 % |
| 2005 | 94.77 % | -1,363.29 % | -1,363.29 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 94.77 % | -1,363.29 % | -1,363.29 % |
| 2006 | 94.77 % | -815.5 % | -875.19 % |
| 2007 | 94.77 % | -880.42 % | -937.76 % |
| 2008 | 94.77 % | -287.12 % | -336.36 % |
| 2009 | 94.77 % | -204.08 % | -186.73 % |
| 2010 | 94.77 % | -431.75 % | -295.24 % |
| 2011 | 94.77 % | -368.13 % | -320.88 % |
| 2012 | 94.77 % | -349.38 % | -333.33 % |
| 2013 | 94.77 % | -560.71 % | -532.14 % |
| 2014 | 94.77 % | -1,088.89 % | -1,088.89 % |
| 2015 | 94.77 % | -2,080.1 % | -925.73 % |
| 2016 | 94.77 % | -95.97 % | -88.22 % |
| 2017 | 122.51 % | -133.17 % | -133.17 % |
| 2018 | 89.43 % | -103.64 % | -99.74 % |
| 2019 | 90.54 % | -25.84 % | -23.31 % |
| 2020 | 92.32 % | -18.33 % | -18.9 % |
| 2021 | 94.67 % | -10.79 % | -15.79 % |
| 2022 | 94.68 % | -0.62 % | -2.88 % |
| 2023 | 93.29 % | -8.04 % | -7.45 % |
| 2024 | 94.77 % | 2.58 % | 5.02 % |
| 2025e | 94.77 % | 7.8 % | 7.22 % |
| 2026e | 94.77 % | 16.72 % | 14.15 % |
| 2027e | 94.77 % | 22.18 % | 18.41 % |
| 2028e | 94.77 % | 21.3 % | 16.36 % |
| 2029e | 94.77 % | 24.95 % | 17.83 % |
| 2030e | 94.77 % | 0 % | 18.9 % |
Polynovo Aktienanalyse
What does Polynovo do?
Polynovo Ltd is an Australian BioTech company that specializes in the development and manufacturing of medical implants. The company was founded in 1986 under the name Regeneus Ltd and is headquartered in Melbourne. Polynovo's history began with the development of products for the veterinary field. In 2000, the company received approval for the sale of its first human products, which were used for wound treatment. In 2014, the company was renamed Polynovo to emphasize its focus on biological implants for human tissue. Polynovo utilizes a revolutionary technology called NovoSorb, which allows for the production of biodegradable polymer films in various shapes and sizes. These are then used as implants in the human body and naturally degrade within a predetermined timeframe. Polynovo is divided into various divisions, including wound care, plastic surgery, and orthopedics. In wound care, the company offers products that aim to prevent infections and promote natural healing processes. The plastic surgery division provides implants for breast reconstruction and fat transplantation. In orthopedics, Polynovo manufactures implants for joints, bones, and tendons. An example of a Polynovo product is NovoSorb BTM (Biodegradable Temporary Matrix), which is used in burns and other skin defects. The matrix stimulates healing and the formation of new tissue, restoring a normal appearance to the patient. Polynovo's business model is based on long-term relationships with hospitals, medical professionals, and government agencies. The company heavily invests in research and development to continuously improve and expand its technology and product range. Through partnerships with other companies and academic institutions, Polynovo is working towards global distribution of its products. Overall, Polynovo has received various awards over the years, including an innovation award from the Australian Trade Commission, and has been recognized multiple times as one of Australia's fastest-growing companies. In conclusion, Polynovo is an innovative and successful company specializing in the development and manufacturing of biological implants. Thanks to its NovoSorb technology, the company can offer products that help accelerate the healing process and facilitate faster patient recovery. Polynovo ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Polynovo's Profit Margins
The profit margins of Polynovo represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Polynovo's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Polynovo's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Polynovo's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Polynovo’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Polynovo stock
How has the profit developed compared to last year?
The profit has increased by 79.84% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Polynovo publish its earnings?
Polynovo publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Polynovo?
The profits of Polynovo are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Polynovo?
You can learn more about the earnings of Polynovo by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Polynovo pay?
Over the past 12 months, Polynovo paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Polynovo is expected to pay a dividend of 0 AUD.
What is the dividend yield of Polynovo?
The current dividend yield of Polynovo is .
When does Polynovo pay dividends?
Polynovo pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Polynovo?
Polynovo paid dividends every year for the past 0 years.
What is the dividend of Polynovo?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Polynovo located?
Polynovo is assigned to the 'Health' sector.
Wann musste ich die Aktien von Polynovo kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Polynovo from 3/7/2025 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 3/7/2025.
When did Polynovo pay the last dividend?
The last dividend was paid out on 3/7/2025.
What was the dividend of Polynovo in the year 2024?
In the year 2024, Polynovo distributed 0 AUD as dividends.
In which currency does Polynovo pay out the dividend?
The dividends of Polynovo are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Polynovo
Our stock analysis for Polynovo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Polynovo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
